Company Filing History:
1 out of 832,843 Years Active: 2004
Title: Rüdiger Horstkorte: Innovator in Recombinant Glycoproteins
Introduction
Rüdiger Horstkorte is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. His work has implications for various medical applications, especially in the human circulatory system.
Latest Patents
Horstkorte holds a patent for "Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof." This invention relates to novel recombinant glycoproteins that serve as messenger substances, signaling substances, promoters, stimulators, and initiators in the animal, particularly human, circulation system. The patent details a method for producing these glycoproteins and outlines their use in pharmaceutical agents. Specifically, it focuses on recombinant human glycoproteins, including differentiation factors, growth factors, thrombolytic agents, thromboprophylactic agents, coagulation factors, interferons, and interleukins.
Career Highlights
Throughout his career, Rüdiger Horstkorte has demonstrated a commitment to advancing medical science through innovative research. His patent reflects a deep understanding of biochemistry and its applications in medicine. His work has the potential to improve therapeutic strategies for various health conditions.
Collaborations
Horstkorte has collaborated with notable colleagues, including Werner Reutter and Rudolf Tauber. These partnerships have likely contributed to the depth and breadth of his research, enhancing the impact of his inventions.
Conclusion
Rüdiger Horstkorte's contributions to the field of recombinant glycoproteins exemplify the importance of innovation in biotechnology. His patent not only showcases his expertise but also holds promise for future medical advancements.